ASX - By Stock
|
GMN |
Re:
Ann: Significant anomalies identified on Ronaldinho REE Project
|
|
Rev1
|
22 |
5.3K |
1 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
22
|
5.3K
|
1
|
|
ASX - By Stock
|
GMN |
Re:
GMN General discussion
|
|
Rev1
|
1.2K |
294K |
2 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
1.2K
|
294K
|
2
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Director retirement and appointment of independent Chairman
|
|
Rev1
|
163 |
66K |
0 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
163
|
66K
|
0
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Director retirement and appointment of independent Chairman
|
|
Rev1
|
163 |
66K |
2 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
163
|
66K
|
2
|
|
ASX - By Stock
|
CGB |
Re:
CANNTAB IS GO
|
|
Rev1
|
104 |
34K |
1 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
104
|
34K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
CANNTAB IS GO
|
|
Rev1
|
104 |
34K |
6 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
104
|
34K
|
6
|
|
ASX - By Stock
|
CGB |
Re:
CANNTAB IS GO
|
|
Rev1
|
104 |
34K |
3 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
104
|
34K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Proposed issue of securities - CGB
|
|
Rev1
|
19 |
8.6K |
3 |
18/09/21 |
18/09/21 |
ASX - By Stock
|
19
|
8.6K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Director retirement and appointment of independent Chairman
|
|
Rev1
|
163 |
66K |
14 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
163
|
66K
|
14
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Listing Rule 3.10A and s708A Notices
|
|
Rev1
|
5 |
3.1K |
1 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
5
|
3.1K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Proposed issue of securities - CGB
|
|
Rev1
|
9 |
4.4K |
2 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
9
|
4.4K
|
2
|
|
ASX - By Stock
|
CGB |
Re:
Ann: CANNTAB ARRIVES IN AUSTRALIA
|
|
Rev1
|
141 |
59K |
0 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
141
|
59K
|
0
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Appointments of COO and Director of Sales and Marketing
|
|
Rev1
|
14 |
7.2K |
8 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
14
|
7.2K
|
8
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Rev1
|
26 |
10K |
5 |
07/08/21 |
07/08/21 |
ASX - By Stock
|
26
|
10K
|
5
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Rev1
|
26 |
10K |
2 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
26
|
10K
|
2
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Rev1
|
107 |
51K |
1 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
107
|
51K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Rev1
|
107 |
51K |
5 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
107
|
51K
|
5
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Rev1
|
107 |
51K |
1 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
107
|
51K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Rev1
|
107 |
51K |
4 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
107
|
51K
|
4
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Canntab Update
|
|
Rev1
|
26 |
10K |
3 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
26
|
10K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Why the silence?
|
|
Rev1
|
12 |
6.0K |
6 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
12
|
6.0K
|
6
|
|
ASX - By Stock
|
CGB |
Re:
Why the silence?
|
|
Rev1
|
12 |
6.0K |
0 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
12
|
6.0K
|
0
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Rev1
|
107 |
51K |
1 |
29/05/21 |
29/05/21 |
ASX - By Stock
|
107
|
51K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Rev1
|
107 |
51K |
5 |
24/05/21 |
24/05/21 |
ASX - By Stock
|
107
|
51K
|
5
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Rev1
|
107 |
51K |
2 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
107
|
51K
|
2
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Rev1
|
107 |
51K |
3 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
107
|
51K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Rev1
|
107 |
51K |
2 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
107
|
51K
|
2
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Rev1
|
107 |
51K |
7 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
107
|
51K
|
7
|
|
ASX - By Stock
|
CGB |
Re:
Ann: WESTERN SYDNEY UNIVERSITY TO UNDERTAKE CLINICAL TRIALS
|
|
Rev1
|
40 |
21K |
4 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
40
|
21K
|
4
|
|
ASX - By Stock
|
CGB |
Re:
Fresh Start
|
|
Rev1
|
69 |
30K |
3 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
69
|
30K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Export Permit Granted for Patented Canntab Hard Pill
|
|
Rev1
|
95 |
32K |
3 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
95
|
32K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Export Permit Granted for Patented Canntab Hard Pill
|
|
Rev1
|
95 |
32K |
9 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
95
|
32K
|
9
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Export Permit Granted for Patented Canntab Hard Pill
|
|
Rev1
|
95 |
32K |
1 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
95
|
32K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Trading Halt
|
|
Rev1
|
74 |
32K |
5 |
27/03/21 |
27/03/21 |
ASX - By Stock
|
74
|
32K
|
5
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Trading Halt
|
|
Rev1
|
74 |
32K |
0 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
74
|
32K
|
0
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Trading Halt
|
|
Rev1
|
74 |
32K |
4 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
74
|
32K
|
4
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Trading Halt
|
|
Rev1
|
74 |
32K |
7 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
74
|
32K
|
7
|
|
ASX - By Stock
|
CGB |
Re:
Ann: CANNTAB GRANTED AUSTRALIAN PATENT
|
|
Rev1
|
72 |
30K |
8 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
72
|
30K
|
8
|
|
ASX - By Stock
|
CGB |
Re:
Bauxite..
|
|
Rev1
|
16 |
8.2K |
0 |
21/03/21 |
21/03/21 |
ASX - By Stock
|
16
|
8.2K
|
0
|
|
ASX - By Stock
|
CGB |
Re:
CGB DISCUSSION
|
|
Rev1
|
44 |
17K |
0 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
44
|
17K
|
0
|
|
ASX - By Stock
|
CGB |
Re:
Ann: CANNTAB GRANTED AUSTRALIAN PATENT
|
|
Rev1
|
72 |
30K |
4 |
14/03/21 |
14/03/21 |
ASX - By Stock
|
72
|
30K
|
4
|
|
ASX - By Stock
|
CGB |
Re:
Ann: CANNTAB GRANTED AUSTRALIAN PATENT
|
|
Rev1
|
72 |
30K |
3 |
14/03/21 |
14/03/21 |
ASX - By Stock
|
72
|
30K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Ann: CANNTAB GRANTED AUSTRALIAN PATENT
|
|
Rev1
|
72 |
30K |
1 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
72
|
30K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
Ann: CANNTAB GRANTED AUSTRALIAN PATENT
|
|
Rev1
|
72 |
30K |
2 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
72
|
30K
|
2
|
|
ASX - By Stock
|
CGB |
Re:
Ann: CANNTAB PRODUCTS TO LAUNCH IN AUSTRALIA
|
|
Rev1
|
137 |
49K |
0 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
137
|
49K
|
0
|
|
ASX - By Stock
|
CGB |
Re:
Ann: CANNTAB PRODUCTS TO LAUNCH IN AUSTRALIA
|
|
Rev1
|
137 |
49K |
4 |
06/03/21 |
06/03/21 |
ASX - By Stock
|
137
|
49K
|
4
|
|
ASX - By Stock
|
CGB |
Re:
Ann: CANNTAB PRODUCTS TO LAUNCH IN AUSTRALIA
|
|
Rev1
|
137 |
49K |
1 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
137
|
49K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
General Discussion Cannabis
|
|
Rev1
|
183 |
66K |
0 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
183
|
66K
|
0
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Rev1
|
40 |
12K |
1 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
40
|
12K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Rev1
|
40 |
12K |
1 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
40
|
12K
|
1
|
|